These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 27494888
21. Profiling of the Bcl-2/Bcl-X(L)-binding sites on type 1 IP(3) receptor. Monaco G, Beckers M, Ivanova H, Missiaen L, Parys JB, De Smedt H, Bultynck G. Biochem Biophys Res Commun; 2012 Nov 09; 428(1):31-5. PubMed ID: 23058917 [Abstract] [Full Text] [Related]
22. The Bcl-2 protein family member Bok binds to the coupling domain of inositol 1,4,5-trisphosphate receptors and protects them from proteolytic cleavage. Schulman JJ, Wright FA, Kaufmann T, Wojcikiewicz RJH. J Biol Chem; 2013 Aug 30; 288(35):25340-25349. PubMed ID: 23884412 [Abstract] [Full Text] [Related]
23. Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl. Monaco G, Decrock E, Akl H, Ponsaerts R, Vervliet T, Luyten T, De Maeyer M, Missiaen L, Distelhorst CW, De Smedt H, Parys JB, Leybaert L, Bultynck G. Cell Death Differ; 2012 Feb 30; 19(2):295-309. PubMed ID: 21818117 [Abstract] [Full Text] [Related]
24. New Insights in the IP3 Receptor and Its Regulation. Parys JB, Vervliet T. Adv Exp Med Biol; 2020 Feb 30; 1131():243-270. PubMed ID: 31646513 [Abstract] [Full Text] [Related]
25. The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor. Rong YP, Bultynck G, Aromolaran AS, Zhong F, Parys JB, De Smedt H, Mignery GA, Roderick HL, Bootman MD, Distelhorst CW. Proc Natl Acad Sci U S A; 2009 Aug 25; 106(34):14397-402. PubMed ID: 19706527 [Abstract] [Full Text] [Related]
27. The Stability and Expression Level of Bok Are Governed by Binding to Inositol 1,4,5-Trisphosphate Receptors. Schulman JJ, Wright FA, Han X, Zluhan EJ, Szczesniak LM, Wojcikiewicz RJ. J Biol Chem; 2016 May 27; 291(22):11820-8. PubMed ID: 27053113 [Abstract] [Full Text] [Related]
28. The BRCA1 tumor suppressor binds to inositol 1,4,5-trisphosphate receptors to stimulate apoptotic calcium release. Hedgepeth SC, Garcia MI, Wagner LE, Rodriguez AM, Chintapalli SV, Snyder RR, Hankins GD, Henderson BR, Brodie KM, Yule DI, van Rossum DB, Boehning D. J Biol Chem; 2015 Mar 13; 290(11):7304-13. PubMed ID: 25645916 [Abstract] [Full Text] [Related]
29. CISD2 counteracts the inhibition of ER-mitochondrial calcium transfer by anti-apoptotic BCL-2. Loncke J, de Ridder I, Kale J, Wagner L, Kaasik A, Parys JB, Kerkhofs M, Andrews DW, Yule D, Vervliet T, Bultynck G. Biochim Biophys Acta Mol Cell Res; 2025 Jan 13; 1872(1):119857. PubMed ID: 39370046 [Abstract] [Full Text] [Related]
30. Reciprocal sensitivity of diffuse large B-cell lymphoma cells to Bcl-2 inhibitors BIRD-2 versus venetoclax. Vervloessem T, Akl H, Tousseyn T, De Smedt H, Parys JB, Bultynck G. Oncotarget; 2017 Dec 19; 8(67):111656-111671. PubMed ID: 29340082 [Abstract] [Full Text] [Related]
31. Calcium regulation of inositol 1,4,5-trisphosphate receptors. Joseph SK, Brownell S, Khan MT. Cell Calcium; 2005 Dec 19; 38(6):539-46. PubMed ID: 16198415 [Abstract] [Full Text] [Related]
32. TRPC channel interactions with calmodulin and IP3 receptors. Zhu MX, Tang J. Novartis Found Symp; 2004 Dec 19; 258():44-58; discussion 58-62, 98-102, 263-6. PubMed ID: 15104175 [Abstract] [Full Text] [Related]
34. The IP3 receptor/Ca2+ channel and its cellular function. Mikoshiba K. Biochem Soc Symp; 2007 Dec 19; (74):9-22. PubMed ID: 17233576 [Abstract] [Full Text] [Related]
35. The type 2 inositol 1,4,5-trisphosphate receptor, emerging functions for an intriguing Ca²⁺-release channel. Vervloessem T, Yule DI, Bultynck G, Parys JB. Biochim Biophys Acta; 2015 Sep 19; 1853(9):1992-2005. PubMed ID: 25499268 [Abstract] [Full Text] [Related]
36. Intracellular calcium release is required for caspase-3 and -9 activation. Tantral L, Malathi K, Kohyama S, Silane M, Berenstein A, Jayaraman T. Cell Biochem Funct; 2004 Sep 19; 22(1):35-40. PubMed ID: 14695652 [Abstract] [Full Text] [Related]
37. Stable expression and function of the inositol 1,4,5-triphosphate receptor requires palmitoylation by a DHHC6/selenoprotein K complex. Fredericks GJ, Hoffmann FW, Rose AH, Osterheld HJ, Hess FM, Mercier F, Hoffmann PR. Proc Natl Acad Sci U S A; 2014 Nov 18; 111(46):16478-83. PubMed ID: 25368151 [Abstract] [Full Text] [Related]
38. Combined Pharmacophore and Grid-Independent Molecular Descriptors (GRIND) Analysis to Probe 3D Features of Inositol 1,4,5-Trisphosphate Receptor (IP3R) Inhibitors in Cancer. Ismatullah H, Jabeen I. Int J Mol Sci; 2021 Nov 30; 22(23):. PubMed ID: 34884798 [Abstract] [Full Text] [Related]
39. A kinetic model of single and clustered IP3 receptors in the absence of Ca2+ feedback. Shuai J, Pearson JE, Foskett JK, Mak DO, Parker I. Biophys J; 2007 Aug 15; 93(4):1151-62. PubMed ID: 17526578 [Abstract] [Full Text] [Related]
40. Dissecting the neuroprotective interaction between the BH4 domain of BCL-w and the IP3 receptor. Tang SX, Camara CM, Franco JA, Pazyra-Murphy MF, Li Y, Godes M, Moyer BM, Bird GH, Segal RA, Walensky LD. Cell Chem Biol; 2024 Oct 17; 31(10):1815-1826.e5. PubMed ID: 39067448 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]